Retinoic Acid Alters the Intracellular Trafficking of the Mannose-6-phosphate/insulin-like Growth Factor II Receptor and Lysosomal Enzymes

Overview

Journal Proc Natl Acad Sci U S A

Specialty Science

Date 1998 Nov 13

PMID 9811861

Citations 17

Authors

J X Kang

J Bell

A Leaf

R L BEARD

R A Chandraratna

Affiliations

Soon will be listed here.

Abstract

Previously, we showed that retinoic acid (RA) binds to the mannose-6-phosphate/insulin-like growth factor II receptor (M6P/IGF2R) with high affinity, suggesting that M6P/IGF2R may be a receptor for RA. Here, we show that RA, after 2-3 h of incubation with cultured neonatal-rat cardiac fibroblasts, dramatically alters the intracellular distribution of M6P/IGF2R as well as that of cathepsin B (a lysosomal protease bearing M6P). Immunofluorescence techniques indicate that this change in intracellular distribution is characterized by a shift of the proteins from the perinuclear area to cytoplasmic vesicles. The effect of RA was neither blocked by an RA nuclear receptor antagonist (AGN193109) nor mimicked by a selective RA nuclear-receptor agonist (TTNPB). Furthermore, the RA-induced translocation of cathepsin B was not observed in M6P/IGF2R-deficient P388D1 cells but occurred in stably transfected P388D1 cells expressing the receptor, suggesting that the effect of RA might be the result of direct interaction with M6P/IGF2R, rather than the result of binding to the nuclear receptors. These observations not only support the idea that M6P/IGF2R mediates an RA-response pathway but also indicate a role for RA in control of intracellular trafficking of lysosomal enzymes. Therefore, our observations may have important implications for the understanding of the diverse biological effects of retinoids.

Citing Articles

Elucidating the cellular determinants of targeted membrane protein degradation by lysosome-targeting chimeras.

Ahn G, Riley N, Kamber R, Wisnovsky S, Moncayo von Hase S, Bassik M Science. 2023; 382(6668):eadf6249.

PMID: 37856615 PMC: 10766146. DOI: 10.1126/science.adf6249.

Drug screening identifies tazarotene and bexarotene as therapeutic agents in multiple sulfatase deficiency.

Schlotawa L, Tyka K, Kettwig M, Ahrens-Nicklas R, Baud M, Berulava T EMBO Mol Med. 2023; 15(3):e14837.

PMID: 36789546 PMC: 9994482. DOI: 10.15252/emmm.202114837.

Somatostatin-Mediated Regulation of Retinoic Acid-Induced Differentiation of SH-SY5Y Cells: Neurotransmitters Phenotype Characterization.

Singh S, Somvanshi R, Kumar U Biomedicines. 2022; 10(2).

PMID: 35203546 PMC: 8961784. DOI: 10.3390/biomedicines10020337.

Wilm's tumor 1 promotes memory flexibility.

Mariottini C, Munari L, Gunzel E, Seco J, Tzavaras N, Hansen J Nat Commun. 2019; 10(1):3756.

PMID: 31434897 PMC: 6704057. DOI: 10.1038/s41467-019-11781-x.

Stable Expression and Characterization of an Optimized Mannose Receptor.

Vigerust D, Vick S, Shepherd V J Clin Cell Immunol. 2015; 6(3).

PMID: 26581716 PMC: 4645283. DOI: 10.4172/2155-9899.1000330.

References

Oka Y, Rozek L, Czech M . Direct demonstration of rapid insulin-like growth factor II Receptor internalization and recycling in rat adipocytes. Insulin stimulates 125I-insulin-like growth factor II degradation by modulating the IGF-II receptor recycling process. J Biol Chem. 1985; 260(16):9435-42. View

Dennis P, Rifkin D . Cellular activation of latent transforming growth factor beta requires binding to the cation-independent mannose 6-phosphate/insulin-like growth factor type II receptor. Proc Natl Acad Sci U S A. 1991; 88(2):580-4. PMC: 50855. DOI: 10.1073/pnas.88.2.580. View

Sohar I, Sleat D, Gong Liu C, Ludwig T, Lobel P . Mouse mutants lacking the cation-independent mannose 6-phosphate/insulin-like growth factor II receptor are impaired in lysosomal enzyme transport: comparison of cation-independent and cation-dependent mannose 6-phosphate receptor-deficient mice. Biochem J. 1998; 330 ( Pt 2):903-8. PMC: 1219223. DOI: 10.1042/bj3300903. View

Johnson A, Klein E, Gillett S, Wang L, Song T, PINO M . Synthesis and characterization of a highly potent and effective antagonist of retinoic acid receptors. J Med Chem. 1995; 38(24):4764-7. DOI: 10.1021/jm00024a003. View

Wang S, Souza R, Kong D, Yin J, Smolinski K, Zou T . Deficient transforming growth factor-beta1 activation and excessive insulin-like growth factor II (IGFII) expression in IGFII receptor-mutant tumors. Cancer Res. 1997; 57(13):2543-6. View

Boehm M, McClurg M, Pathirana C, Mangelsdorf D, White S, Hebert J . Synthesis of high specific activity [3H]-9-cis-retinoic acid and its application for identifying retinoids with unusual binding properties. J Med Chem. 1994; 37(3):408-14. DOI: 10.1021/jm00029a013. View

DE SOUZA A, Hankins G, Washington M, Orton T, Jirtle R . M6P/IGF2R gene is mutated in human hepatocellular carcinomas with loss of heterozygosity. Nat Genet. 1995; 11(4):447-9. DOI: 10.1038/ng1295-447. View

Yamada T, DE SOUZA A, Finkelstein S, Jirtle R . Loss of the gene encoding mannose 6-phosphate/insulin-like growth factor II receptor is an early event in liver carcinogenesis. Proc Natl Acad Sci U S A. 1997; 94(19):10351-5. PMC: 23366. DOI: 10.1073/pnas.94.19.10351. View

Moallem S, Hales B . Induction of apoptosis and cathepsin D in limbs exposed in vitro to an activated analog of cyclophosphamide. Teratology. 1995; 52(1):3-14. DOI: 10.1002/tera.1420520103. View

10.

Wang Z, Fung M, Barlow D, Wagner E . Regulation of embryonic growth and lysosomal targeting by the imprinted Igf2/Mpr gene. Nature. 1994; 372(6505):464-7. DOI: 10.1038/372464a0. View

11.

Sue S, Chari R, Kong F, Mills J, Fine R, Jirtle R . Transforming growth factor-beta receptors and mannose 6-phosphate/insulin-like growth factor-II receptor expression in human hepatocellular carcinoma. Ann Surg. 1995; 222(2):171-8. PMC: 1234775. DOI: 10.1097/00000658-199508000-00009. View

12.

Piao Z, Choi Y, Park C, Lee W, Park J, Kim H . Deletion of the M6P/IGF2r gene in primary hepatocellular carcinoma. Cancer Lett. 1998; 120(1):39-43. DOI: 10.1016/s0304-3835(97)00289-9. View

13.

Deiss L, Galinka H, Berissi H, Cohen O, Kimchi A . Cathepsin D protease mediates programmed cell death induced by interferon-gamma, Fas/APO-1 and TNF-alpha. EMBO J. 1996; 15(15):3861-70. PMC: 452079. View

14.

Ludwig T, Eggenschwiler J, Fisher P, DErcole A, Davenport M, Efstratiadis A . Mouse mutants lacking the type 2 IGF receptor (IGF2R) are rescued from perinatal lethality in Igf2 and Igf1r null backgrounds. Dev Biol. 1996; 177(2):517-35. DOI: 10.1006/dbio.1996.0182. View

15.

Kornfeld S . Structure and function of the mannose 6-phosphate/insulinlike growth factor II receptors. Annu Rev Biochem. 1992; 61:307-30. DOI: 10.1146/annurev.bi.61.070192.001515. View

16.

Klein E, PINO M, Johnson A, Davies P, Nagpal S, Thacher S . Identification and functional separation of retinoic acid receptor neutral antagonists and inverse agonists. J Biol Chem. 1996; 271(37):22692-6. DOI: 10.1074/jbc.271.37.22692. View

17.

Narvaez C, VanWeelden K, Byrne I, Welsh J . Characterization of a vitamin D3-resistant MCF-7 cell line. Endocrinology. 1996; 137(2):400-9. DOI: 10.1210/endo.137.2.8593782. View

18.

Hanewinkel H, Glossl J, Kresse H . Biosynthesis of cathepsin B in cultured normal and I-cell fibroblasts. J Biol Chem. 1987; 262(25):12351-5. View

19.

Lau M, Stewart C, Liu Z, Bhatt H, Rotwein P, Stewart C . Loss of the imprinted IGF2/cation-independent mannose 6-phosphate receptor results in fetal overgrowth and perinatal lethality. Genes Dev. 1994; 8(24):2953-63. DOI: 10.1101/gad.8.24.2953. View

20.

BEARD R, Chandraratna R, Colon D, Gillett S, Henry E, Marler D . Synthesis and structure-activity relationships of stilbene retinoid analogs substituted with heteroaromatic carboxylic acids. J Med Chem. 1995; 38(15):2820-9. DOI: 10.1021/jm00015a004. View